Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


BioScience News and Advocate Daily Highlights 9/2

Daily Highlights
1. No evidence bird flu passed from humans, WHO says
2. Leftover embryos could benefit research
3. Heart-healthy meat may be on the menu
4. Greenpeace challenges Monsanto patent
5. Balancing risks and benefits - Spiked online debate
6. Big pharma calls on small biotech firm


No evidence bird flu passed from humans, WHO says
Genetic evidence shows bird flu is not being passed from person to person in Vietnam, reassuring news that suggests the outbreaks that have killed 18 people have not become an epidemic, the World Heal...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6128

Leftover embryos could benefit research
It should be legal for leftover embryos from fertility treatments to be used for stem cell research, according to a keynote speaker at this week's New Zealand Bioethics Conference. Gareth Jones, p...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6126

Heart-healthy meat may be on the menu
Fish oils known to help prevent heart attacks can now be made by land animals for themselves, thanks to work by genetic engineers. The researchers inserted a gene from a nematode worm into mice wh...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6124

Greenpeace challenges Monsanto patent
Greenpeace is challenging patent rights to a wheat strain granted to Monsanto, the world's largest genetically modified (GM) seed company, on grounds of "biopiracy." The dispute continues the environm...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6123

Balancing risks and benefits - Spiked online debate
Continuing the Spiked online debate, Dr Gill Samuels of Pfizer writes about balancing the risks and benefits of research.In areas where new science and technologies are being employed, an e...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6120

Big pharma calls on small biotech firm
Three of the world's largest drug makers, Bristol-Myers Squibb, Abbott Laboratories and Eli Lilly, are turning to a tiny Silicon Valley company to help them develop drugs. Troy May writes in the S...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6118


From the BioScience News Team

BioScience Communications Limited
Editor: Christine Ross

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Sky City : Auckland Convention Centre Cost Jumps By A Fifth

SkyCity Entertainment Group, the casino and hotel operator, is in talks with the government on how to fund the increased cost of as much as $130 million to build an international convention centre in downtown Auckland, with further gambling concessions ruled out. The Auckland-based company has increased its estimate to build the centre to between $470 million and $530 million as the construction boom across the country drives up building costs and design changes add to the bill.
More>>

ALSO:

RMTU: Mediation Between Lyttelton Port And Union Fails

The Rail and Maritime Union (RMTU) has opted to continue its overtime ban indefinitely after mediation with the Lyttelton Port of Christchurch (LPC) failed to progress collective bargaining. More>>

Earlier:

Science Policy: Callaghan, NSC Funding Knocked In Submissions

Callaghan Innovation, which was last year allocated a budget of $566 million over four years to dish out research and development grants, and the National Science Challenges attracted criticism in submissions on the government’s draft national statement of science investment, with science funding largely seen as too fragmented. More>>

ALSO:

Scoop Business: Spark, Voda And Telstra To Lay New Trans-Tasman Cable

Spark New Zealand and Vodafone, New Zealand’s two dominant telecommunications providers, in partnership with Australian provider Telstra, will spend US$70 million building a trans-Tasman submarine cable to bolster broadband traffic between the neighbouring countries and the rest of the world. More>>

ALSO:

More:

Statistics: Current Account Deficit Widens

New Zealand's annual current account deficit was $6.1 billion (2.6 percent of GDP) for the year ended September 2014. This compares with a deficit of $5.8 billion (2.5 percent of GDP) for the year ended June 2014. More>>

ALSO:

Still In The Red: NZ Govt Shunts Out Surplus To 2016

The New Zealand government has pushed out its targeted return to surplus for a year as falling dairy prices and a low inflation environment has kept a lid on its rising tax take, but is still dangling a possible tax cut in 2017, the next election year and promising to try and achieve the surplus pledge on which it campaigned for election in September. More>>

ALSO:

Job Insecurity: Time For Jobs That Count In The Meat Industry

“Meat Workers face it all”, says Graham Cooke, Meat Workers Union National Secretary. “Seasonal work, dangerous jobs, casual and zero hours contracts, and increasing pressure on workers to join non-union individual agreements. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news